Emcure Pharmaceuticals Limited (NSE:EMCURE)
1,782.00
+28.80 (1.64%)
Jun 19, 2026, 3:29 PM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 336.71 billion as of June 18, 2026. Its market cap has increased by 33.62% in one year.
Market Cap
336.71B
Enterprise Value
350.71B
Revenue
92.04B
Ranking
n/a
PE Ratio
36.42
Stock Price
1,782.00
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 336.71B, an increase of 31.04%. That is a compound annual growth rate of 14.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 336.71B | 30.17% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 642.48B |
| Glenmark Pharmaceuticals | 624.68B |
| Ipca Laboratories | 402.32B |
| Ajanta Pharma | 382.81B |
| Gland Pharma | 362.30B |
| Wockhardt | 326.79B |
| Piramal Pharma | 211.00B |
| Eris Lifesciences | 200.70B |